HIGHLIGHTS
- who: Sara Steffanoni et al. from the Department of Medicine, Division of Hematology, Valduce Hospital, Como, Italy have published the Article: Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review, in the Journal: (JOURNAL)
- what: Considering the subgroup with PCNSL (n=18, including 6 R/R PCNSL), the safety and efficacy of this approach were demonstrated, and no death or relapse was reported after a median follow-up of 24 months from ASCT. The IELSG43 multicenter randomized trial was designed to compare BCNU/thiotepa-conditioned ASCT versus . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.